当前位置:首页 - 行情中心 - 百洋医药(301015) - 财务分析

百洋医药

(301015)

  

流通市值:145.07亿  总市值:145.07亿
流通股本:5.26亿   总股本:5.26亿

百洋医药(301015)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.91亿元,每股收益1.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益251519.86万元,未分配利润157562.14万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产689638.82万元,负债438118.96万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入6,143,923,658.273,594,708,467.521,661,158,413.817,563,902,600.83
营业总成本5,252,717,606.613,123,535,308.651,441,669,270.276,702,048,433.17
营业利润911,469,828.6477,052,032.77218,925,313.31888,103,896.46
利润总额907,916,950.83474,485,081.15217,571,121.59873,577,654.17
净利润690,576,353.68366,041,224.32164,996,276.84639,883,332.35
其他综合收益-1,596,916.54-1,140,551.27-176,682.38223,343.44
综合收益总额688,979,437.14364,900,673.05164,819,594.46640,106,675.79
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计5,370,923,485.575,148,586,920.694,792,158,126.445,118,319,606.73
非流动资产合计1,525,464,674.47906,658,549.15855,901,636.681,299,160,375.36
资产总计6,896,388,160.046,055,245,469.845,648,059,763.126,417,479,982.09
流动负债合计3,135,223,401.292,591,704,196.141,996,462,752.362,391,555,195.75
非流动负债合计1,245,966,171.11856,825,773.35844,445,108.87906,472,166.58
负债合计4,381,189,572.43,448,529,969.492,840,907,861.233,298,027,362.33
归属于母公司股东权益合计2,310,358,153.992,635,517,392.512,834,325,842.882,946,842,065.23
股东权益合计2,515,198,587.642,606,715,500.352,807,151,901.893,119,452,619.76
负债和股东权益合计6,896,388,160.046,055,245,469.845,648,059,763.126,417,479,982.09
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计6,429,999,941.743,887,894,668.381,941,047,879.538,260,465,523.01
经营活动现金流出小计5,867,575,703.113,538,794,795.381,804,610,754.477,650,761,425.68
经营活动产生的现金流量净额562,424,238.63349,099,873136,437,125.06609,704,097.33
投资活动现金流入小计257,954,800.8310,453,180.815,485,315.8164,254,659.02
投资活动现金流出小计768,391,595.969,249,979.5127,355,768.22223,774,699.44
投资活动产生的现金流量净额-510,436,795.07-58,796,798.7-21,870,452.41-159,520,040.42
筹资活动现金流入小计1,719,270,694.021,193,975,762.41306,094,239.951,432,176,192.53
筹资活动现金流出小计1,863,582,921.13764,343,678.42102,480,598.291,685,873,381.6
筹资活动产生的现金流量净额-144,312,227.11429,632,083.99203,613,641.66-253,697,189.07
汇率变动对现金及现金等价物的影响-3,864,924.45641,303.03428,041.84719,826.28
现金及现金等价物净增加额-96,189,708720,576,461.32318,608,356.15197,206,694.12
期末现金及现金等价物余额1,037,953,705.981,711,176,331.321,309,208,226.15990,599,870
最新报告期:2024-10-29
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
招商证券许菲菲1.622.022.512024-10-29
中泰证券孙宇瑶,祝嘉琦1.551.822.142024-10-28
TOP↑